WGS
GeneDx Holdings Corp.
$40.77
+0.67%
2026-05-08
About GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Key Fundamentals
P/E Ratio
722.23
Forward P/E
18.27
EPS (TTM)
$-2.66
ROE
-30.4%
Revenue Growth (YoY)
17.4%
Profit Margin
-17.6%
Debt/Equity
66.19
Price/Book
3.57
Beta
2.07
Market Cap
$1.12B
Avg Volume (10D)
2.6M
Recent Breakout Signals
No recent breakout signals detected for WGS.
Recent Price Range (60 Days)
60D High
$95.38
60D Low
$32.21
Avg Volume
1.0M
Latest Close
$40.77
Get breakout alerts for WGS
Sign up for Breakout Scanner to receive daily notifications when WGS triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
GeneDx Holdings Corp. (WGS) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors WGS daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. WGS operates in the Healthcare sector within the Diagnostics & Research industry. Data is provided for informational purposes only and does not constitute financial advice.